| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |